Securisyn Medical

Growth Stage

Patented interlocking medical devices prevent costly & deadly tube dislodgement


Raised to Date: Raised: $112,484

Total Commitments ($USD)



Start Date


Close Date


Min. Goal


Max. Goal


Min. Investment


Security Type



Series A

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap




Rolling Commitments ($USD)

Reporting Date


Days Remaining
% of Min. Goal


% of Max. Goal


Likelihood of Max
Avg. Daily Raise


# of Investors


Create a free account today to gain access to KingsCrowd analytics.
Year Founded



Healthcare & Pharmaceuticals

Tech Sector


Distribution Model




Capital Intensity



Littleton, Colorado

Business Type


Securisyn Medical, with a valuation of $40 million, is raising funds on Republic. The company makes patented interlocking medical devices that prevent tube dislodgement. The flagship product of Securisyn Medical is called SolidAIRity Flex and provides endotracheal tube securement for airway stability for ventilated patients. The device works on Securisyn’s patent-pending Interlock Securement System. The company is led by an experienced team and has an exclusive global manufacturing and distribution partnership with SunMed. Arthur Kanowitz founded Securisyn Medical in January 2011. The current crowdfunding campaign has a minimum target of $100,000 and a maximum target of $5 million. The campaign proceeds will be used to fund the commercial launch and expanded adoption of the SolidAIRity Flex device.

Summary Profit and Loss Statement

Most Recent Year Prior Year












Net Income



Summary Balance Sheet

Most Recent Year Prior Year




Accounts Receivable



Total Assets



Short-Term Debt



Long-Term Debt



Total Liabilities



Financials as of: 11/01/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Analyst Report Analyst Report Methodology Article

Healthcare providers commonly use tape to secure breathing tubes used to keep ventilated patients alive. But tape is so unstable that unplanned extubation (the accidental removal of a breathing tube from an airway) is associated with 33,000 preventable deaths each year in the United States. 

The technology is archaic. In fact, it’s a joke. Somehow, no company has stepped forward to offer a product that can prevent the epidemic of endotracheal tube slippage and unplanned extubation. 

Until now.

The company I’m introducing to you today — Securisyn Medical — has patented a tube stabilization device that solves the life-threatening issues surrounding unplanned extubation and tube slippage.

Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Securisyn Medical on Republic 2022
Platform: Republic
Security Type: SAFE
Valuation: $40,000,000

Follow company

Follow Securisyn Medical on Republic 2022

Buy Securisyn Medical's Deal Report

Warning: according to the close date for this deal, Securisyn Medical may no longer be accepting investments.

Securisyn Medical Deal Report

Get KingsCrowd’s comprehensive report on Securisyn Medical including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Securisyn Medical is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise
  • What one of our expert analysts thinks about this investment opportunity

Buy the Securisyn Medical deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge Pro